UBS Equities-China Equity Strategy _Capital market with Chinese character...-108315279
Global Research and Evidence Lab Capital market with Chinese characteristics II: SOE valuation dilemma and potential solutions
报告摘要
Global Research and Evidence Lab Capital market with Chinese characteristics II: SOE valuation dilemma and potential solutions
报告信息
- 文件全名
- 《UBS Equities-China Equity Strategy _Capital market with Chinese character...-108315279.pdf》
- 适合读者
- 核心数据
- double those of SOEs since 2021. However, non-SOEs' earnings growth averaged 11%
- pa over 2014-23, only slightly higher than 9% for SOEs. Average annual ROE for non-
- SOEs over the past decade has been 9.9% versus 8.3% for all SOEs—in the past five
- 600938.SS CNOOC - A Buy 190,972 29.03 40.80 41% 214 -14% 13% 7.1 1.2
- 600028.SS Sinopec - A Buy 107,922 6.41 9.00 40% 126 -13% 21% 12.0 0.9
- 核心议题
常见问题
《UBS Equities-China Equity Strategy _Capital market with Chinese character...-108315279》主要包含哪些内容?
Global Research and Evidence Lab Capital market with Chinese characteristics II: SOE valuation dilemma and potential solutions核心数据:double those of SOEs since 2021. However, non-SOEs' earnings growth averaged 11%;pa over 2014-23, only slightly higher than 9% for SOEs. Average annual ROE for non-;SOEs over the past decade has been 9.9% versus 8.3% for all SOEs—in the past five。
这份报告覆盖哪一年、篇幅多大?
覆盖 2024 年,全文约 28。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合战略规划、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了管理咨询等议题。
继续阅读
查看全部 →